These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6139797)

  • 1. A blood pressure clinic in a developing country.
    Ahmed ME
    Postgrad Med J; 1983 Oct; 59(696):632-3. PubMed ID: 6139797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of hypotensive effect of nadolol].
    Cybulska I; Brym E; Czerniewska E; Wołyńczyk-Niegowska J
    Pol Arch Med Wewn; 1980 Dec; 64(6):475-80. PubMed ID: 6111065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our experience on the clinical use of nadolol].
    Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
    Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
    [No Abstract]   [Full Text] [Related]  

  • 4. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 5. Mediation of blood pressure by nadolol and alpha methyldopa.
    Jenkins AC; Rosenthal J; Stumpe KO
    Practitioner; 1981 Mar; 225(1353):405-9. PubMed ID: 6115378
    [No Abstract]   [Full Text] [Related]  

  • 6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA
    J Fam Pract; 1980 Aug; 11(2):199-205. PubMed ID: 6106039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers for hypertension: are they going out of style?
    Che Q; Schreiber MJ; Rafey MA
    Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract]   [Full Text] [Related]  

  • 12. First-choice antihypertensive drug use in the Glasgow Blood Pressure Clinic.
    Clark DW; Curzio JL; Howie CA; Reid JL
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S120-2. PubMed ID: 1708011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages and benefits of once-daily nadolol treatment in hypertension.
    González D
    J Int Med Res; 1982; 10(5):351-6. PubMed ID: 6754507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
    Zecchi P; Bellocci F; Santarelli P; Iannarelli M
    Clin Ter; 1986 Jan; 116(1):19-24. PubMed ID: 2870837
    [No Abstract]   [Full Text] [Related]  

  • 17. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices].
    Bertel O; Conen D; Renggli I
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of metoprolol and trichlormethiazide in hypertension.
    Stokkeland OM; Sangvik K; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):755-68. PubMed ID: 2449
    [No Abstract]   [Full Text] [Related]  

  • 19. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function in patients with essential hypertension receiving nadolol.
    Waal-Manning HJ; Hobson CH
    Br Med J; 1980 Aug; 281(6237):423-4. PubMed ID: 6107151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.